Statistics In the Pharmaceutical Industry
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
janvier 2023, env. 496 pages, Chapman & Hall/CRC Biostatistics Series, Anglais
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
janvier 2023, env. 496 pages, Chapman & Hall/CRC Biostatistics Series, Anglais
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Autres titres de la collection: Chapman & Hall/CRC Biostatistics Series
Afficher toutMedical Statistics for Cancer Studies
Taylor and Francis, 2024
978-1-032-28587-0
79.00 CHF
disponible de suite
Statistical Analytics for Health Data Science with SAS and R
Taylor and Francis, 2023
978-1-03-232562-0
env. 140.00 CHF
livrable dans env. 10-20 jours
Bayesian Methods in Health Economics
Taylor and Francis, 2023
978-1-03-247753-4
env. 80.00 CHF
livrable dans env. 10-20 jours
Data Science, AI, and Machine Learning in Drug Development
Taylor and Francis, 2022
978-0-367-70807-8
env. 206.00 CHF
livrable dans env. 10-20 jours
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2020
978-0-367-73187-8
env. 86.00 CHF
livrable dans env. 10-20 jours
Artificial Intelligence for Drug Development, Precision Medicine, and Healthcare
Taylor and Francis, 2020
978-0-367-36292-8
env. 206.00 CHF
livrable dans env. 10-20 jours
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2019
978-1-138-73173-8
env. 206.00 CHF
livrable dans env. 10-20 jours
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
An Applied Approach Using SAS & STATA
Taylor and Francis, 2015
978-1-4665-0547-6
env. 146.00 CHF
livrable dans env. 10-20 jours
Benefit-Risk Assessment in Pharmaceutical Research and Development
Taylor and Francis, 2013
978-1-4398-6794-5
env. 156.00 CHF
livrable dans env. 10-20 jours
Autres titres sur ce thème
Probability and Statistics for Engineering and the Sciences, Loose-Leaf Version
Cengage Learning, 2026
979-8-214-02489-9
env. 167.00 CHF
délai de livraison indéterminé
Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease ...
Elsevier, 2026
978-0-443-43946-9
env. 260.00 CHF
livrable dans env. 10-20 jours
Dynamic Programming for Economists
From Basic Growth Models to Computational Methods
Taylor and Francis, 2026
978-1-041-30339-8
env. 85.00 CHF
paraît en juillet
Good Manufacturing Practices for Pharmaceuticals
Taylor and Francis, 2026
978-1-041-00249-9
env. 299.00 CHF
paraît en mai
Multi-Criteria Decision-Making
Principles, Methods and Programs
Taylor and Francis, 2026
978-1-032-85363-5
env. 159.00 CHF
paraît en mars
Handbook of Statistics of Extremes
Taylor and Francis, 2026
978-1-032-51980-7
env. 309.00 CHF
paraît en juillet
Data Science for Sustainable Development Goals
Indian Case Studies
Taylor and Francis, 2026
978-1-032-78131-0
env. 239.00 CHF
paraît en mai
Introduction to Applied Spatial Econometrics
Taylor and Francis, 2027
978-1-4822-3638-5
env. 106.00 CHF
livrable dans env. 10-20 jours
Cellular Therapies for Cancer Treatment
Advancements in Drug Delivery Strategies
Elsevier, 2026
978-0-443-34141-0
env. 229.00 CHF
paraît en octobre
Variably Legal Markets
Rethinking Markets and Crime
Taylor and Francis, 2026
978-0-367-18613-5
env. 249.00 CHF
paraît en mars
Derivatives
Mathematical Foundations for Finance Students
Taylor and Francis, 2026
978-1-032-76219-7
env. 209.00 CHF
paraît en juin